--- title: "Wearable startup CUDIS launches a new health ring line with an AI-fueled ‘coach’" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/276929100.md" description: "Wearables startup CUDIS is launching a new series of health rings featuring an AI ‘agent coach’ to help users achieve fitness goals. The rings incentivize healthy behaviors through a points system redeemable for discounts on health products. The AI coach generates personalized health programs and tracks various body metrics, including sleep quality and stress management. CUDIS has sold over 30,000 units since its first launch in 2024 and has a user base of 250,000 across 103 countries. The company secured $5 million in seed funding and plans to launch a Kickstarter soon." datetime: "2026-02-25T19:11:16.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/276929100.md) - [en](https://longbridge.com/en/news/276929100.md) - [zh-HK](https://longbridge.com/zh-HK/news/276929100.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/276929100.md) | [English](https://longbridge.com/en/news/276929100.md) # Wearable startup CUDIS launches a new health ring line with an AI-fueled ‘coach’ Wearables startup CUDIS is launching its newest series of health rings this week. The updated ring comes equipped with a number of features, including an AI “agent coach” designed to keep users on track to attain their fitness goals. CUDIS says it differentiates itself from other wearables by not just delivering health metrics but also incentivizing healthy behavior through a points system. Users garner digital “health points” for healthy behaviors — things like daily sleep, 10,000 steps every day, sports activities, and conversations with the ring’s AI coach — which can then be redeemed through an integrated marketplace for discounts on health supplements and other products. The ring’s AI Agent Coach, meanwhile, is designed to leverage generative AI to aid with healthy programs for exercise and daily health. The company says that its agent generates tailored programs including “daily tasks, recovery protocols, supplement recommendations, and direct referrals to licensed medical professionals.” The ring also tracks a host of body metrics and daily behaviors, such as sleep quality, stress management, movement, and recovery. This helps them see how these metrics affect their Pace of Aging (PoA), showing whether their body is aging faster or slower than their chronological age, the company explains. CUDIS CEO and co-founder Edison Chen told TechCrunch that since his company’s first wearable was launched in 2024, the company has sold over 30,000 units across its first two models. The app’s user base has also grown to 250,000 users across 103 countries, he added. “Our strongest markets so far have been North America, Europe, and Asia,” Chen said. “What we’re good at is pattern recognition for healthy people trying to optimize,” Chen told TechCrunch. “The AI spots when you’re trending in the wrong direction, such as chronic poor sleep, declining HRV, elevated resting heart rate, and either suggests lifestyle changes or connects you to a professional. The control is in the escalation pathway to the right care access,” he said. Techcrunch event Boston, MA | June 9, 2026 The company claims that it keeps user data encrypted and secure via the Solana blockchain. It has previously been described as a “web3 AI wellness company.” (TechCrunch was not able to test the smart ring directly to verify its security claims.) CUDIS announced $5 million of seed funding in 2024. The round was led by Draper Associates and included a number of other investors, including a number of blockchain-associated investor groups like Skybridge, DraperDragon, Monke Ventures, and Foresight Ventures, among others. The company also plans to launch a Kickstarter soon. ### 相關股票 - [Curis (CRIS.US)](https://longbridge.com/zh-HK/quote/CRIS.US.md) - [Direxion S&P Biotech Bear 3X (LABD.US)](https://longbridge.com/zh-HK/quote/LABD.US.md) - [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md) - [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md) - [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md) - [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-HK/quote/XLV.US.md) - [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md) - [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md) - [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md) - [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-HK/quote/ARKG.US.md) - [VG Health (VHT.US)](https://longbridge.com/zh-HK/quote/VHT.US.md) - [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md) - [iShares Global Healthcare (IXJ.US)](https://longbridge.com/zh-HK/quote/IXJ.US.md) - [iShares US Pharma (IHE.US)](https://longbridge.com/zh-HK/quote/IHE.US.md) ## 相關資訊與研究 - [Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update](https://longbridge.com/zh-HK/news/281525623.md) - [InSilico Medicine Strikes Multi-Billion-Dollar AI Drug Discovery Deal With Eli Lilly](https://longbridge.com/zh-HK/news/280909399.md) - [Gaudium IVF Launches AI-Led Infertility Treatment in India First](https://longbridge.com/zh-HK/news/281416110.md) - [Lantern receives FDA clearance for paediatric STAR-001 CNS trial](https://longbridge.com/zh-HK/news/281102581.md) - [BUZZ-Tempus AI rises after study shows AI-driven alerts improve heart valve treatment](https://longbridge.com/zh-HK/news/281390073.md)